Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May;15(3):285.
doi: 10.2450/2017.0032-17. Epub 2017 Mar 2.

Recommendations for factor VIII product source to treat patients with haemophilia A

Romano Arcieri  1 , Gabriele Calizzani  2 , Fabio Candura  2 , Pier Mannuccio Mannucci  3
Affiliations
Comment

Recommendations for factor VIII product source to treat patients with haemophilia A

Romano Arcieri et al. Blood Transfus. 2017 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclaimer of conflicts of interest

The Authors declare no conflicts of interest, with the exception of PMM who declares having received in the past 12 months honoraria for lectures as a speaker or for chairing symposia organised by Alexion, Bayer, Baxalta-Shire, Grifols, Kedrion, LFB, and Novo Nordisk. He has also acted as a scientific consultant for Bayer and Kedrion.

Comment on

References

    1. Coppola A, Santagostino E, Hassan HJ, et al. The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A. Blood Transfus. 2017;15:281–2. - PMC - PubMed
    1. Arcieri R, Calizzani G, Candura F, Mannucci PM. The increased demand for plasma-derived factor VIII in Italy. Blood Transfus. 2017;15:279–80. - PMC - PubMed
    1. Mannucci PM, Mancuso ME, Santagostino E. How we choose factor VIII to treat hemophilia. Blood. 2012;119:4108–14. - PubMed
    1. Peyvandi F, Mannucci PM, Garagiola I, et al. A randomized trial of factor VIII and neutralizing antibodies in hemophilia A. N Engl J Med. 2016;374:2054–64. - PubMed